Skip to Main Content

Author Details

Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
1999
119
25
PMIDPaper TitleJournal TitlePublished Year
36117467Genomic landscape of multiple Bowen's disease using whole-exome sequencing.J Dermatol2023
37460394A stepwise approach to fine needle aspiration cytology of lymph nodes.J Pathol Transl Med2023
37409441Radiological and pathological analysis of the galaxy sign in patients with pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma.Thorac Cancer2023
36721307Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience.Cancer Med2023
36533870Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.Exp Dermatol2023
36938660Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.J Dermatol2023
34480890Genomic Progression of Precancerous Actinic Keratosis to Squamous Cell Carcinoma.J Invest Dermatol2022
35600403Long-Term Clinical Outcomes in Treatment-Naïve Patients With Orbital Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Single-Center Study.Front Oncol2022
35054389Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics.Diagnostics (Basel)2022
32745376Lymphoepithelioid variant of peripheral T cell lymphoma (Lennert lymphoma): Cytologic and histologic features.Diagn Cytopathol2021
33708623Emerging Role of Consolidative Radiotherapy After Complete Remission Following R-CHOP Immunochemotherapy in Stage III-IV Diffuse Large B-Cell Lymphoma: A Single Institutional and Case-Matched Control Study.Front Oncol2021
33669569Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis: A Multicenter Study.Diagnostics (Basel)2021
33811972Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease.Exp Hematol2021
33413597The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase.Stem Cell Res Ther2021
32586381CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.Stem Cell Res Ther2020
33255487Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma.Diagnostics (Basel)2020
33255420FDG PET/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings.Diagnostics (Basel)2020
32629802CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b Signaling.Cancers (Basel)2020
32854491A machine-learning expert-supporting system for diagnosis prediction of lymphoid neoplasms using a probabilistic decision-tree algorithm and immunohistochemistry profile database.J Pathol Transl Med2020
31456859Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma.Nucl Med Mol Imaging2019
31754896Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas.EJNMMI Res2019
33405525Accelerated Bone Regeneration via Three-Dimensional Cell-Printed Constructs Containing Human Nasal Turbinate-Derived Stem Cells as a Clinically Applicable Therapy.ACS Biomater Sci Eng2019
30204524Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model.Immunol Invest2019
27599769Intracranial relapse as a solitary mass of ocular adnexal lymphoma of the mucosa-associated lymphoid tissue type.Korean J Intern Med2018
30006304Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.Biol Blood Marrow Transplant2018
29335408Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen.Nat Commun2018
28761088Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function.Sci Rep2017
28449640CD34 + tumours of the orbit including solitary fibrous tumours: a six-case series.BMC Ophthalmol2017
28592786Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.J Pathol Transl Med2017
28664615Cutaneous epithelioid hemangioendothelioma on the sole mimicking a pyogenic granuloma.Australas J Dermatol2017
28526296Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.J Invest Dermatol2017
24935527First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma.Asia Pac J Clin Oncol2016
26442657MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.Mucosal Immunol2016
28035211Induction of Indoleamine 2,3-dioxygenase by Pre-treatment with Poly(I:C) May Enhance the Efficacy of MSC Treatment in DSS-induced Colitis.Immune Netw2016
27684851FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome.Medicine (Baltimore)2016
28030899Analysis of treatment outcomes for primary tonsillar lymphoma.Radiat Oncol J2016
27175513Role of follow-up endoscopic examination in treatment response assessment for patients with gastric diffuse large B cell lymphoma.Scand J Gastroenterol2016
27145367BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.Oncotarget2016
27310987Myeloid sarcoma of the Gingiva with myelodysplastic syndrome: A Case Report.Medicine (Baltimore)2016
26100211MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma.Histopathology2016
25961653Diffuse Large B-Cell Lymphoma of the Peri-Implant Mucosa Mimicking Peri-Implantitis.J Oral Implantol2016
25381826An Unusual Presentation of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma as Diffuse Pulmonary Infiltrates with Spontaneous Regression.Cancer Res Treat2015
26398122A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.Oncol Rep2015
26552489Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.Mol Cells2015
26722400Liquid-based cytology in the fine needle aspiration of parathyroid lesions: a comparison study with the conventional smear, ThinPrep, and SurePath.Int J Clin Exp Pathol2015
26140044Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow.Immune Netw2015
26023039Erratum to: Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance.Ann Surg Oncol2015
25968616Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance.Ann Surg Oncol2015
26017177Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.Mol Ther2015
25728714Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML).Ann Hematol2015
  • 1 - 50 of 119

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
College of Medicine and Health Sciences, United Arab Emirates University
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 0
12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 0
Inha University Hospital
Career Start Year 1999
Number of shared co-authors 0
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Western University
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 2
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Kanazawa Medical Center Kanazawa Japan.
Career Start Year 1990
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 1989
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Chugai Pharmaceutical Co. Ltd.
Career Start Year 1984
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 0
University of Utah
Career Start Year 1982
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 0
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Hannover Medical School
Co-authored papers 5
Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers 4
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 2
University Institute of Pharma Sciences, Chandigarh University
Co-authored papers 2
Present address: Dxige Research Inc.
Co-authored papers 1
Seoul National University Hospital
Co-authored papers 1
University of British Columbia
Co-authored papers 1
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 1
Haeundae Paik Hospital, Inje University College of Medicine
Co-authored papers 1
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Co-authored papers 1
University of Colorado School of Medicine
Co-authored papers 1
University of British Columbia
Co-authored papers 1
Soonchunhyang University College of Medicine, Bucheon Hospital
Co-authored papers 1
Co-authored papers 1
University of Texas Health Science Center at Houston
Co-authored papers 1
Co-authored papers 1
Pohang University of Science and Technology
Co-authored papers 1
College of Veterinary Medicine, Iowa State University
Co-authored papers 1
Pohang University of Science and Technology
Co-authored papers 1